Mibavademab
米瓦德单抗
Report date: 2026/03/28 20:00:32
Base Information
Drug NameMibavademab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[7]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRegeneron Pharmaceuticals Inc
China Registration ClassN/A
Develop Information
Active CompaniesEli Lilly And CompanyRegeneron Pharmaceuticals Inc
Inactive CompaniesN/A
Active Indications +[4]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A